PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A two-dose schedule could make HIV vaccines more effective

MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later

2024-09-20
(Press-News.org)

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines. 

Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutralizing antibodies. However, a multidose vaccine regimen administered over a short time is not practical for mass vaccination campaigns. 

In a new study, the researchers have now found that they can achieve a similar immune response with just two doses, given one week apart. The first dose, which is much smaller, prepares the immune system to respond more powerfully to the second, larger dose.  

This study, which was performed by bringing together computational modeling and experiments in mice, used an HIV envelope protein as the vaccine. A single-dose version of this vaccine is now in clinical trials, and the researchers hope to establish another study group that will receive the vaccine on a two-dose schedule.

“By bringing together the physical and life sciences, we shed light on some basic immunological questions that helped develop this two-dose schedule to mimic the multiple-dose regimen,” says Arup Chakraborty, the John M. Deutch Institute Professor at MIT and a member of MIT’s Institute for Medical Engineering and Science and the Ragon Institute of MIT, MGH and Harvard University.

This approach may also generalize to vaccines for other diseases, Chakraborty notes.

Chakraborty and Darrell Irvine, a former MIT professor of biological engineering and materials science and engineering and member of the Koch Institute for Integrative Cancer Research, who is now a professor of immunology and microbiology at the Scripps Research Institute, are the senior authors of the study, which appears in Science Immunology. The lead authors of the paper are Sachin Bhagchandani PhD ’23 and Leerang Yang PhD ’24.

Neutralizing antibodies

Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections. One promising vaccine now in clinical trials consists of an HIV protein called an envelope trimer, along with a nanoparticle called SMNP. The nanoparticle, developed by Irvine’s lab, acts as an adjuvant that helps recruit a stronger B cell response to the vaccine. 

In clinical trials, this vaccine and other experimental vaccines have been given as just one dose. However, there is growing evidence that a series of doses is more effective at generating broadly neutralizing antibodies. The seven-dose regimen, the researchers believe, works well because it mimics what happens when the body is exposed to a virus: The immune system builds up a strong response as more viral proteins, or antigens, accumulate in the body. 

In the new study, the MIT team investigated how this response develops and explored whether they could achieve the same effect using a smaller number of vaccine doses. 

“Giving seven doses just isn’t feasible for mass vaccination,” Bhagchandani says. “We wanted to identify some of the critical elements necessary for the success of this escalating dose, and to explore whether that knowledge could allow us to reduce the number of doses.” 

The researchers began by comparing the effects of one, two, three, four, five, six, or seven doses, all given over a 12-day period. They initially found that while three or more doses generated strong antibody responses, two doses did not. However, by tweaking the dose intervals and ratios, the researchers discovered that giving 20 percent of the vaccine in the first dose and 80 percent in a second dose, seven days later, achieved just as good a response as the seven-dose schedule.

“It was clear that understanding the mechanisms behind this phenomenon would be crucial for future clinical translation,” Yang says. “Even if the ideal dosing ratio and timing may differ for humans, the underlying mechanistic principles will likely remain the same.”

Using a computational model, the researchers explored what was happening in each of these dosing scenarios. This work showed that when all of the vaccine is given as one dose, most of the antigen gets chopped into fragments before it reaches the lymph nodes. Lymph nodes are where B cells become activated to target a particular antigen, within structures known as germinal centers.

When only a tiny amount of the intact antigen reaches these germinal centers, B cells can’t come up with a strong response against that antigen.

However, a very small number of B cells do arise that produce antibodies targeting the intact antigen. So, giving a small amount in the first dose does not “waste” much antigen but allows some B cells and antibodies to develop. If a second, larger dose is given a week later, those antibodies bind to the antigen before it can be broken down and escort it into the lymph node. This allows more B cells to be exposed to that antigen and eventually leads to a large population of B cells that can target it.

“The early doses generate some small amounts of antibody, and that’s enough to then bind to the vaccine of the later doses, protect it, and target it to the lymph node. That's how we realized that we don't need to give seven doses,” Bhagchandani says. “A small initial dose will generate this antibody and then when you give the larger dose, it can again be protected because that antibody will bind to it and traffic it to the lymph node.”

T-cell boost

Those antigens may stay in the germinal centers for weeks or even longer, allowing more B cells to come in and be exposed to them, making it more likely that diverse types of antibodies will develop.

The researchers also found that the two-dose schedule induces a stronger T-cell response. The first dose activates dendritic cells, which promote inflammation and T-cell activation. Then, when the second dose arrives, even more dendritic cells are stimulated, further boosting the T-cell response.

Overall, the two-dose regimen resulted in a fivefold improvement in the T-cell response and a 60-fold improvement in the antibody response, compared to a single vaccine dose.

“Reducing the ‘escalating dose’ strategy down to two shots makes it much more practical for clinical implementation. Further, a number of technologies are in development that could mimic the two-dose exposure in a single shot, which could become ideal for mass vaccination campaigns,” Irvine says. 

The researchers are now studying this vaccine strategy in a nonhuman primate model. They are also working on specialized materials that can deliver the second dose over an extended period of time, which could further enhance the immune response.

The research was funded by the Koch Institute Support (core) Grant from the National Cancer Institute, the National Institutes of Health, and the Ragon Institute of MIT, MGH, and Harvard.

###

Written by Anne Trafton, MIT News

END



ELSE PRESS RELEASES FROM THIS DATE:

Wastewater monitoring can detect foodborne illness, researchers find

Wastewater monitoring can detect foodborne illness, researchers find
2024-09-20
UNIVERSITY PARK, Pa. — First used in the 1940s to monitor for polio, wastewater surveillance proved such a powerful disease monitoring tool that the U.S. Centers for Disease Control and Prevention (CDC) established the National Wastewater Surveillance System to support SARS-CoV-2 monitoring in September of 2020. Now, a team of scientists from Penn State and the Pennsylvania Department of Health have shown that domestic sewage monitoring is useful for a foodborne pathogen as well.  In findings published today (Sept. 19) in the Journal of Clinical ...

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards
2024-09-20
Building equipment and envelope scientists at the Department of Energy’s Oak Ridge National Laboratory were recognized for research excellence during the ASHRAE 2024 summer conference held in Indianapolis. Stephen Kowalski and Mikael Salonvaara received the Distinguished Service Award, which salutes members who have served the society with distinction in chapter, regional and society activities. Kowalski and Salonvaara have each been active members of ASHRAE for more than 25 years and have supported the organization’s Technical and Standards Project Committees. ASHRAE is the largest international professional organization ...

SkAI launched to further explore universe

2024-09-20
Funded by a five-year, $20 million grant from the U.S. National Science Foundation (NSF) and the Simons Foundation, the National Center for Supercomputing Applications is partnering with other academic institutions and federal laboratories in the Midwest to develop new artificial intelligence (AI) tools to advance astrophysics research and exploration of the universe. Led by Northwestern University, the collaboration will establish the NSF-Simons AI Institute for the Sky or SkAI (pronounced “sky”), one of two AI research centers that will help astronomers better understand the cosmos. Located close to NCSA’s home in Illinois, SkAI will ...

SLU researchers identify sex-based differences in immune responses against tumors

2024-09-20
ST. LOUIS — Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, part of the body’s “smart system” that monitors for threats and fights them with customized defenses.  "Therapies that use the patient's immune system to fight their disease have a lot of potential to ...

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities
2024-09-20
By Andy Flick, Evolutionary Studies scientific coordinator In a groundbreaking study led by Sarah Worthan, Ph.D., a postdoctoral researcher in the Behringer Lab at Vanderbilt University, scientists have successfully evolved microbial cultures that possess the ability to sense pH changes, enabling rapid responses to environmental fluctuations. Along with highlighting the power of lab-driven evolution, this discovery also led to finding similar mutations in nature in emerging pathogens and coral symbionts—organisms that navigate challenging pH shifts in their environments and are ...

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

2024-09-20
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient. The approach, detailed in the journal Cell Stem Cell, uses patients’ own tumor cells that replicate the unique characteristics of a patient's tumor allowing scientists to quickly screen a large number of drugs in order to identify personalized treatments that can target this rare and diverse group of cancers. “Sarcoma is a rare and complex disease, which makes conducting clinical trials ...

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

2024-09-20
A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research. “We are excited about this drug compound because we might have the possibility to develop the first cure for Parkinson’s disease, at least for a subset of patients,” said lead author Kalle Gehring, a Professor in the Department of Biochemistry at McGill University and Canada Research Chair in Structural Studies of Neurodegenerative Diseases. While Parkinson’s symptoms — slowed movements, tremors and balance problems — often appear in ...

Deforestation in the Amazon is driven more by domestic demand than by the export market

Deforestation in the Amazon is driven more by domestic demand than by the export market
2024-09-20
Brazilian Legal Amazonia (BLA) – which comprises the entirety of the Amazon Basin located in Brazil and vast adjacent swathes of the Cerrado, spanning nine states – is more than 5 million square kilometers (km2) in area and corresponds to almost 60% of the country’s land mass. Almost a quarter of this area (23%) has been deforested, and over 1 million km2 are degraded, so that the region risks reaching an ecological tipping point at which ecosystems collapse and billions of tons of carbon are released into the atmosphere. Some parts of ...

Demand-side actions could help construction sector deliver on net-zero targets

2024-09-20
Using state-of-the-art energy efficiency technologies to renovate existing properties and construct new ones could enable Europe’s construction sector to almost eliminate its carbon emissions by 2060, a new study suggests. Published in the journal Renewable and Sustainable Energy Reviews, the research is the first to fully assess the potential for energy demand reduction across the construction sectors of the United Kingdom and all European Union member states. It highlights that 75% of Europe’s building stock is currently classed as energy inefficient, with total floor space also ...

Research team discovers molecular mechanism for a bacterial infection

Research team discovers molecular mechanism for a bacterial infection
2024-09-20
Virginia Tech researchers have learned how bacteria manipulate molecules to infect the host organism. Daniel Capelluto and his research team have discovered the mechanism by which the bacterial pathogen Shigella flexneri, the causative agent of dysentery, manipulates molecular activity to assure its survival against its host’s natural defenses. Their findings were recently published in Structure, a Cell Press journal that supports open access.  “This infection strategy may be employed by other bacteria, making this research a potential foundation for understanding the molecular mechanisms underlying various bacterial infections,” said Capelluto, associate professor ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] A two-dose schedule could make HIV vaccines more effective
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later